Literature DB >> 16935293

Making V(D)J rearrangement visible: quantification of recombination efficiency in real time at the single cell level.

Xiao Zheng1, Klaus Schwarz.   

Abstract

V(D)J recombination is of fundamental importance for the diversity of immunoglobulin and T cell receptor genes. An enhanced green fluorescent protein (EGFP) based assay was successfully developed to monitor V(D)J recombination efficiency. This assay makes V(D)J recombination visible at the single cell level in real time. Surprisingly, despite a high (60% to 90%) transfection efficiency, the EGFP based V(D)J recombination efficiency was found to be low ( approximately 1%) in 293 cells. The EGFP based V(D)J recombination efficiency correlated well with that achieved by the classical V(D)J recombination assay. The EGFP based V(D)J recombination efficiency depended on the relative RAG (recombination activating gene)-1 and RAG-2 but not Artemis expression vector concentrations used for co-transfection. A rise of RAG-1 dosage increased recombination efficiency. In contrast, a surplus of RAG-2 inhibited V(D)J recombination efficiency. The test differentiates RAG null mutants as seen in human severe combined immunodeficiency (SCID).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935293     DOI: 10.1016/j.jim.2006.07.012

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.

Authors:  Zheng Xiao; Steven M Yannone; Elizabeth Dunn; Morton J Cowan
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

2.  Detecting variable (V), diversity (D) and joining (J) gene segment recombination using a two-colour fluorescence system.

Authors:  Gina B Scott; Erika A de Wynter; Graham P Cook
Journal:  Mob DNA       Date:  2010-03-01

3.  A Novel Quantitative Fluorescent Reporter Assay for RAG Targets and RAG Activity.

Authors:  Inês Trancoso; Marie Bonnet; Rui Gardner; Jorge Carneiro; Vasco M Barreto; Jocelyne Demengeot; Leonor M Sarmento
Journal:  Front Immunol       Date:  2013-05-16       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.